[A new method of hemostasis with porous nikelide-titan cryoapplicator in percutaneous approach to the kidney].
The aim of the study was improvement of percutaneous interventions outcomes by introduction of innovation--cryohemostasis of the wound for arrest and prevention of hemorrhage. A total of 242 percutaneous roentgenoendoscopic operations were made in 2004-2006. Intensive intra- and postoperative hemorrhage arose in 17 (7.02%) patients. An original technique of wound hemostasis and prevention of postoperative hemorrhage with cryoapplicator made of porous nikelide-titan alloy was tried in 122 patients. None of these patients developed hemorrhage. High efficacy of the method was confirmed by a fall oferythrocyte count and hemoglobin in irrigation liquid: after cryohemostasis their level decreased 13 and 150 fold, respectively. The catalase method corrects hematuria in patients after cryohemostasis much earlier than in patients after conventional hemostasis. The proposed technique of hemostasis and prevention of hemorrhage from percutaneous wound canal proved highly effective even at early stages of its investigation, is simple in application, cost-effective.